Isis Pharmaceuticals, Inc. (ISIS) Posts Q2 EPS Loss of $0.18

August 4, 2011 6:03 PM EDT
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) reported Q2 EPS of ($0.18), $0.04 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $24.8 million versus the consensus estimate of $23.98 million.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Add Your Comment